Hims & Hers shares tumble after company misses on margin, says may stop selling some weight loss drugs Hims & Hers Health reported fourth-quarter results on Monday that beat analysts’ expectations, but the stock sank in extended trading.

Shares of Hims & Hers tumble 26% after FDA says semaglutide is no longer in shortage Shares of Hims & Hers tumble 26% after FDA says semaglutide is no longer in shortage

Hims & Hers donates $1 million to Trump’s inauguration fund OpenAI CEO Sam Altman and Meta both announced $1 million donations, and Amazon and Apple CEO Tim Cook have also reportedly contributed.